Bristol-Myers' ipilimumab delayed

FDA extended the PDUFA date for a BLA from Bristol-Myers Squibb Co. (NYSE:BMY) for ipilimumab to March 26, 2011, from Dec. 25. Bristol-Myers said it submitted further analysis of data, which the agenc...